PineBridge Investments’s Halozyme HALO Stock Holding History

PineBridge Investments’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,355	Closed	-$734K	–	540
2026 Q1	$734K	Sell	11,355 -1,928	-15%	-$136K	0.01%	409
2025 Q4	$894K	Buy	13,283 +1,669	+14%	+$112K	0.01%	429
2025 Q3	$852K	Buy	+11,614	New	+$771K	0.01%	442
2025 Q2	–	Sell	-11,466	Closed	-$732K	–	641
2025 Q1	$732K	Sell	11,466 -27,701	-71%	-$1.61M	0.01%	578
2024 Q4	$1.87M	Buy	39,167 +11,716	+43%	+$601K	0.01%	572
2024 Q3	$1.57M	Buy	+27,451	New	+$1.57M	0.01%	563

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

PineBridge Investments's HALO Position: Q2 2026 in Review

PineBridge Investments sold out of Halozyme (HALO) in Q2 2026, closing a stake of 11,355 shares — an estimated $734K sold.

PineBridge Investments first reported a position in HALO in Q3 2024 and held it in 6 quarters. The position peaked at $1.87M in Q4 2024. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

PineBridge Investments reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
PineBridge Investments sold 11,355 Halozyme shares in Q2 2026, an estimated $734K.
PineBridge Investments first reported a position in Halozyme in Q3 2024 and held it in 6 quarters.
PineBridge Investments's Halozyme position peaked at $1.87M in Q4 2024.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on PineBridge Investments's 13F filing for Q2 2026, filed 14 Aug 2026.